Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
VitaDX
company
About
VitaDX develops a non-invasive solution for early bladder cancer diagnosis.
- 11 - 50
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €2M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, VisioCyt®, dedicated to the detection of cancer of the bladder. This solution will allow the diagnosis of bladder cancer from a simple urine sample to improve the performance of urinary cytology conventionally used in first intention.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€3M
VitaDX has raised a total of
€3M
in funding over 2 rounds. Their latest funding was raised on
Sep 4, 2020 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 4, 2020 | Debt Financing | €2M | 2 | — | — | Detail |
| Sep 4, 2020 | Series Unknown | €1M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
VitaDX is funded by 3 investors.
CIC Ouest
and Banque Populaire Grand-Ouest
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
CIC Ouest
|
— | Debt Financing |
Banque Populaire Grand-Ouest
|
— | Debt Financing |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
